Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 47
Page 47 of 114 · 1029 articles
Medical Board Investigations: The First Contact
How medical board complaints move from intake to investigator contact, whether interview requests are truly voluntary, and how to…
Treble Damages and Per-Claim Penalties Explained
Treble damages and per-claim penalties can turn a small False Claims Act sample into a seven-figure demand fast for healthcare pro…
Speaker Programs and Kickback Enforcement
OIG's Special Fraud Alert put physician speaker programs under Anti-Kickback Statute scrutiny, and 2025 settlements confirm active…
Remote Therapeutic Monitoring Billing Compliance
CPT 98975 through 98981 cover Remote Therapeutic Monitoring, a distinct billing structure from RPM with its own data, documentatio…
Podiatry Wound Care Audits
Routine foot care exclusions, at-risk exception documentation, and debridement coding standards are driving new Medicare audits of…
Responding to a Wound Care ADR From Your MAC
The 45-day deadline, chart elements MAC reviewers check, and submission mechanics for a wound care Additional Documentation Reques…
Originating Site Rules and Their Audit Consequences
Medicare's telehealth originating site waiver runs through 2027, but audits test each claim against the rule in effect on its date…
License Renewal Disclosure Questions: Answering Accurately
State board renewals ask about arrests, convictions, and malpractice actions, and a false or incomplete answer is its own discipli…
License Reinstatement After Revocation
State boards and OIG program exclusions run separate reinstatement tracks, each with its own timing and its own standard for the r…